Skip to main content
logo
Day One Biopharmaceuticals, Inc. (DAWN)
NASDAQ: DAWN · Real-Time Price · USD
21.42
+0.02 (0.07%)
Mar 27, 2026, 2:15 PM EDT - Market open

DAWN Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
2,2129601,2811,2741,5811,044
Market Cap Growth
148.30%-25.08%0.60%-19.44%51.43%-
Enterprise Value
1,775521.3752.01907.171,239759.6
Last Close Price
21.429.3212.6714.6021.5216.85
PE Ratio
--8.96-12.42-6.16-9.92-3.65
PS Ratio
13.996.079.77---
PB Ratio
5.002.182.553.674.763.71
P/TBV Ratio
5.012.182.353.364.242.22
P/FCF Ratio
--9.22-15.96-8.66-14.38-21.51
P/OCF Ratio
--9.25-16.40-8.67-14.39-21.51
EV/Sales Ratio
11.223.305.73---
EV/EBITDA Ratio
--4.21-3.49-4.41-8.46-10.47
EV/EBIT Ratio
--4.08-3.46-4.40-8.43-10.44
EV/FCF Ratio
--5.01-9.37-6.17-11.27-15.65
Debt / Equity Ratio
0.010.010.0100.000.00
Debt / EBITDA Ratio
-0.02-0.02-0.010.00-0.010.00
Debt / FCF Ratio
-0.03-0.03-0.030.00-0.010.00
Net Debt / Equity Ratio
-0.99-0.99-1.05-1.06-1.03-1.01
Net Debt / EBITDA Ratio
3.543.542.461.782.333.92
Net Debt / FCF Ratio
4.214.216.592.493.115.85
Asset Turnover
0.290.290.27000
Inventory Turnover
3.573.573.18---
Quick Ratio
7.737.737.4312.4220.6032.84
Current Ratio
8.028.027.6612.7220.9433.43
Return on Equity (ROE)
-22.74%-22.74%-22.49%-55.68%-46.37%-44.83%
Return on Assets (ROA)
-23.85%-23.85%-41.66%-56.84%-45.99%-43.37%
Return on Invested Capital (ROIC)
2088.81%2088.81%993.10%1430.21%2377.55%5184.82%
Return on Capital Employed (ROCE)
-26.71%-26.71%-50.77%-60.70%-47.88%-44.79%
Earnings Yield
-4.85%-11.16%-8.05%-16.23%-10.08%-27.42%
FCF Yield
-4.70%-10.84%-6.27%-11.55%-6.95%-4.65%
Buyback Yield / Dilution
-10.70%-10.70%-16.87%-21.85%-77.13%-568.42%
Total Shareholder Return
-10.70%-10.70%-16.87%-21.85%-77.13%-568.42%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q